TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A paper published in The Lancet Healthy Longevity argues that sarcopenia and age-related mobility loss should be understood as problems involving the wider motor system, not muscle alone. The authors call for practical tests and studies that assess nerve and muscle function, while acknowledging that the proposed approach has not yet been shown to improve outcomes or reduce costs.
A paper published in The Lancet Healthy Longevity argues that age-related weakness and mobility loss should not be treated as muscle problems alone, proposing that sarcopenia be understood as a condition of the wider motor system, including the brain, spinal cord, nerves and muscles. The authors say the proposal could reshape assessment and research, but note that new tests have not yet been shown to improve patient outcomes or reduce costs.
The paper, titled Reframing sarcopenia as a disease of the ageing motor system, says the clinical definition of sarcopenia has already moved beyond muscle size. Measures such as grip strength, walking speed and chair stands are used because they predict falls, disability and death better than muscle mass alone, the authors report. They argue that explanations and treatments have not kept pace with this shift.
According to the authors, muscle loss accounts for only a modest share of the decline in strength seen with age. They point to differences in strength and mobility between people with similar muscle mass, and to exercise improving function even when measured muscle mass does not change. Their proposed explanation includes age-related changes in the brain and spinal cord, the reliability and strength of nerve signals, balance and the ability to sense body position.
The authors propose looking beyond whether someone can complete a movement. They suggest assessing how quickly a person rises from a chair, whether they become unsteady during sustained effort, hand dexterity, and walking while talking. They also recommend closer examination when weakness is asymmetric, rapid or disproportionate to muscle loss. The paper notes that sedative and anticholinergic medicines can blunt motor drive, making medication review relevant alongside strength training.
Rethinking How Weakness Is Assessed
The proposal matters because a muscle-only approach may miss other contributors to a person’s difficulty walking, standing or maintaining balance. If the authors’ model is supported by further research, assessment could focus more closely on which parts of movement are impaired, helping clinicians distinguish among different causes of weakness rather than assuming that reduced muscle size explains it.
The issue has practical stakes for older people and health services. The source report says falls remain Australia’s leading cause of injury-related hospitalization and death. It cites 253,800 fall-related hospitalizations in 2024–25; in the previous year, 6,722 Australians died following a fall, and fall injuries were estimated to cost the health system $5.4 billion. These figures describe the Australian burden and do not establish that the proposed motor-system approach would reduce falls.
The authors argue that a broader model could redirect research and investment toward interventions that improve everyday function, not just muscle mass. That is a rationale for further work, rather than evidence that existing muscle-building treatments are ineffective across the board or that the proposed framework has already improved care.
Products Worth Considering
BowFlex Results Series SelectTech 552 Adjustable Dumbbell
Bowflex SelectTech 840 Adjustable Kettlebell
BowFlex Results Series SelectTech Dumbbells
As an affiliate, we earn on qualifying purchases.
From Muscle Mass to Movement
Sarcopenia refers to the substantial loss of muscle, strength and physical function associated with aging. The report says it affects up to 29% of community-dwelling older adults, with higher rates in hospitals and residential elder care and among people with multiple health conditions or frailty. Sarcopenia contributes to frailty, disability and loss of independence, but the reported prevalence varies by setting and population.
Earlier in 2026, the Australian Journal of General Practice published a proposed algorithm to guide primary-care screening, assessment and management of poor muscle health, according to the source report. The new paper, by Lucas B. R. Orssatto and colleagues, builds on a shift in diagnosis toward functional measures. It calls for international working groups responsible for diagnostic criteria to consider a five-point agenda, though the supplied report does not detail each point.
“We propose that sarcopenia is better understood as a disease of the aging motor system.”
— Lucas B. R. Orssatto and co-authors, in their 2026 paper in The Lancet Healthy Longevity
Evidence Gaps in the Proposed Tests
The paper presents a framework and research agenda, not proof that motor-system screening improves care. The authors say the suggested measures have not been shown to outperform existing screens on patient outcomes or cost. The report also says access to neuromuscular expertise is uneven in primary care, which could affect whether more detailed assessments are practical.
It is not yet clear which tests would be reliable and feasible for routine use, how they should change treatment decisions, or whether they would prevent falls or preserve independence. The source material does not provide trial results comparing the proposed approach with current care, nor does it establish that any particular medication or muscle-focused treatment should be stopped.
Testing the Motor-System Framework
The authors call for investment in studies to validate practical assessments, guidelines that support a staged approach, and trials that measure nerve function as well as muscle. International working groups that set sarcopenia criteria are a proposed audience for their five-point agenda. The paper does not specify a timetable for those reviews or for clinical trials.
For now, the proposal is best understood as a call to broaden research and clinical attention, not a replacement for current screening guidance. Whether the approach leads to more accurate assessment, better-targeted interventions or fewer falls will depend on evidence from future validation studies and trials.
Key Questions
What does the paper mean by the motor system?
It refers to the parts of the body involved in producing movement, including the brain, spinal cord, nerves and muscles, as well as functions such as balance and sensing body position.
Does the paper say muscle loss is irrelevant?
No. The authors argue that muscle loss is only one part of age-related weakness and may explain a modest share of strength decline. Their proposal is to assess the wider systems that contribute to movement as well.
Are the suggested assessments ready for routine use?
That has not been established. The authors say the proposed measures have not yet been shown to outperform existing screens on outcomes or cost, and call for studies to validate tests that are practical in primary care.
Why does this matter for falls?
Weakness and impaired mobility can contribute to falls, which cause substantial injury and health-system costs. The paper proposes a broader way to investigate weakness, but it does not show that this approach reduces falls.
Source: medicalxpress.com
